Updates are available Correction dated 2025-06-25
Click to view Correction: https://doi.org/10.1038/s41467-025-61277-0
-
Authors
Xiao, Jiayang
Adkinson, Joshua A.
Myers, John
Allawala, Anusha B.
Mathura, Raissa K.
Pirtle, Victoria
Najera, Ricardo
Provenza, Nicole R. https://orcid.org/0000-0002-6952-5417
Bartoli, Eleonora
Watrous, Andrew J.
Oswalt, Denise https://orcid.org/0000-0001-6260-5636
Gadot, Ron
Anand, Adrish https://orcid.org/0000-0002-6673-6251
Shofty, Ben https://orcid.org/0000-0002-2949-4740
Mathew, Sanjay J. https://orcid.org/0000-0002-2715-6641
Goodman, Wayne K.
Pouratian, Nader https://orcid.org/0000-0002-0426-3241
Pitkow, Xaq
Bijanki, Kelly R. https://orcid.org/0000-0003-1624-8767
Hayden, Benjamin https://orcid.org/0000-0002-7678-4281
Sheth, Sameer A. https://orcid.org/0000-0001-8770-8965
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (UH3 NS103549)
U.S. Department of Health & Human Services | National Institutes of Health (K01 MH116364)
U.S. Department of Health & Human Services | National Institutes of Health (R21 NS104953)
U.S. Department of Health & Human Services | National Institutes of Health (UH3 NS100549)
U.S. Department of Health & Human Services | National Institutes of Health (MH114854)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 15 September 2023
Accepted: 7 June 2024
First Online: 15 July 2024
Change Date: 25 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-025-61277-0
Competing interests
: S.A.S. has consulting agreements with Boston Scientific, NeuroPace, Abbott, and Zimmer Biomet. W.K.G. receives royalties from Nview, LLC and OCDscales, LLC. S.J.M. has served as a consultant to the following companies: Almatica Pharma, Biohaven, BioXcel Therapeutics, Boehringer-Ingelheim, Brii Biosciences, Clexio Biosciences, COMPASS Pathways, Delix Therapeutics, Douglas Pharmaceuticals, Eleusis, Engrail Therapeutics, Freedom Biosciences, Janssen, Liva Nova, Levo Therapeutics, Merck, Neumora, Neurocrine, Perception Neurosciences, Praxis Precision Medicines, Relmada Therapeutics, Sage Therapeutics, Seelos Therapeutics, Signant Health, Sunovion, Xenon Pharmaceuticals, and XW Pharma. S.J.M. has received research support from Boehringer-Ingelheim, Engrail Therapeutics, Merck, Neurocrine, and Sage Therapeutics. N.P. is a consultant for Abbott Laboratories and Sensoria Therapeutics. The remaining authors declare no competing interests.
